In this blog, Jill Hagenkord, MD, outlines the evidence needed to achieve widespread clinical adoption and reimbursement coverage for new medical devices from a private insurer’s perspective.
This blog is adapted from Dr. Hagenkord’s special lecture at the 2022 Symposium.
“Available technologies cannot reach the regions of the brain involved in psychiatric disorders. This is where focused ultrasound comes into play. If the results of this study are positive, the data will serve as a strong foundation for the future development of innovative treatments for a variety of psychiatric disorders.”
‒ Noah S. Philip, MD
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.